Ontology highlight
ABSTRACT:
SUBMITTER: Murakami Y
PROVIDER: S-EPMC9749925 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
Murakami Yuki Y Osawa Hinata H Kurohara Takashi T Yanase Yuta Y Ito Takahito T Yokoo Hidetomo H Shibata Norihito N Naito Mikihiko M Aritake Kosuke K Demizu Yosuke Y
RSC medicinal chemistry 20220923 12
Degradation of hematopoietic prostaglandin D<sub>2</sub> synthase (H-PGDS) by proteolysis-targeting chimeras (PROTACs) is expected to be important in the treatment of allergic diseases and Duchenne's muscular dystrophy. We recently reported that <b>PROTAC(H-PGDS)-</b>7 (<b>PROTAC</b>1), which is composed of H-PGDS inhibitor (TFC-007) and cereblon (CRBN) E3 ligase ligand (pomalidomide), showed potent H-PGDS degradation activity. Here, we investigated the structure-activity relationships of <b>PRO ...[more]